Matches in Wikidata for { <http://www.wikidata.org/entity/Q104484307> ?p ?o ?g. }
Showing items 1 to 92 of
92
with 100 items per page.
- Q104484307 description "2020 ވަނަ އަހަރުގެ ޑިސެމްބަރުމަހުގެ 9ވަނަ ދުވަހު ޝާއިރުކުރެވުނު ސައިންޓިފިކް ލިޔުމެއް" @default.
- Q104484307 description "artículu científicu espublizáu n'avientu de 2020" @default.
- Q104484307 description "bài báo khoa học" @default.
- Q104484307 description "scientific article published on 09 December 2020" @default.
- Q104484307 description "wetenschappelijk artikel" @default.
- Q104484307 description "наукова стаття, опублікована 9 грудня 2020" @default.
- Q104484307 name "Impact of molecular subtype on 1325 early-stage breast cancer patients homogeneously treated with hypofractionated radiotherapy without boost: Should the indications for radiotherapy be more personalized?" @default.
- Q104484307 name "Impact of molecular subtype on 1325 early-stage breast cancer patients homogeneously treated with hypofractionated radiotherapy without boost: Should the indications for radiotherapy be more personalized?" @default.
- Q104484307 name "Impact of molecular subtype on 1325 early-stage breast cancer patients homogeneously treated with hypofractionated radiotherapy without boost: Should the indications for radiotherapy be more personalized?" @default.
- Q104484307 type Item @default.
- Q104484307 label "Impact of molecular subtype on 1325 early-stage breast cancer patients homogeneously treated with hypofractionated radiotherapy without boost: Should the indications for radiotherapy be more personalized?" @default.
- Q104484307 label "Impact of molecular subtype on 1325 early-stage breast cancer patients homogeneously treated with hypofractionated radiotherapy without boost: Should the indications for radiotherapy be more personalized?" @default.
- Q104484307 label "Impact of molecular subtype on 1325 early-stage breast cancer patients homogeneously treated with hypofractionated radiotherapy without boost: Should the indications for radiotherapy be more personalized?" @default.
- Q104484307 prefLabel "Impact of molecular subtype on 1325 early-stage breast cancer patients homogeneously treated with hypofractionated radiotherapy without boost: Should the indications for radiotherapy be more personalized?" @default.
- Q104484307 prefLabel "Impact of molecular subtype on 1325 early-stage breast cancer patients homogeneously treated with hypofractionated radiotherapy without boost: Should the indications for radiotherapy be more personalized?" @default.
- Q104484307 prefLabel "Impact of molecular subtype on 1325 early-stage breast cancer patients homogeneously treated with hypofractionated radiotherapy without boost: Should the indications for radiotherapy be more personalized?" @default.
- Q104484307 P1433 Q104484307-C95223AE-0FF4-438D-9F2D-E7078247CB77 @default.
- Q104484307 P1476 Q104484307-4EACA223-30F1-4F41-8798-04AE13B3D8CC @default.
- Q104484307 P2093 Q104484307-1F4F4D95-CDEE-410F-8EC2-1BA450FC926E @default.
- Q104484307 P2093 Q104484307-23EF6B88-5D3E-4F1E-8577-555814790508 @default.
- Q104484307 P2093 Q104484307-3A7D548B-7E60-420C-8FB8-87B272DD1FE4 @default.
- Q104484307 P2093 Q104484307-411B38D6-A3DC-4864-A9CD-F2CBDF29615C @default.
- Q104484307 P2093 Q104484307-419B89F1-78ED-4A59-BC69-D41F2E0C73BF @default.
- Q104484307 P2093 Q104484307-55633F58-1B0A-4F80-9DB6-3657ADFEBFE8 @default.
- Q104484307 P2093 Q104484307-5A60BCA9-0149-4260-9E1D-89A578CABE1C @default.
- Q104484307 P2093 Q104484307-60CE4017-2599-4C52-801D-42963C6DFAA2 @default.
- Q104484307 P2093 Q104484307-652AD11F-45C6-4CBA-BA20-6E5B55826527 @default.
- Q104484307 P2093 Q104484307-67C13AD8-E3FF-4E98-B5C9-F610D829FF21 @default.
- Q104484307 P2093 Q104484307-67F9655B-B153-424C-B1D3-907F44267F0B @default.
- Q104484307 P2093 Q104484307-69D97AAC-AD75-40E8-A4D7-AADC5E1A6984 @default.
- Q104484307 P2093 Q104484307-8A30D209-1144-43A6-A155-3550414DB64C @default.
- Q104484307 P2093 Q104484307-91228D16-0FE2-4C5F-A9C3-578B333816AB @default.
- Q104484307 P2093 Q104484307-9B0AD604-74DD-4A8C-8A35-DA90353E02D1 @default.
- Q104484307 P2093 Q104484307-A8C6EB16-8812-4CB3-9B58-F45A1348970B @default.
- Q104484307 P2093 Q104484307-C94F3962-08D0-4C68-83BD-1481EC36FD1E @default.
- Q104484307 P2093 Q104484307-CA3B5D56-C5F7-470A-B63B-F3210630FA77 @default.
- Q104484307 P2093 Q104484307-D45D64A4-7477-4975-A71F-02400B9F65A6 @default.
- Q104484307 P2093 Q104484307-F3DD98C7-1038-46FC-B25A-146CAD7CBE2C @default.
- Q104484307 P2093 Q104484307-FF91E6A7-96AE-4B0A-97E2-356D407A8CBF @default.
- Q104484307 P2860 Q104484307-762FF26C-5093-42B7-AB5C-D92F454DAA16 @default.
- Q104484307 P304 Q104484307-D7A621CF-A55E-44B5-B941-A4C2C71B08BF @default.
- Q104484307 P31 Q104484307-432CB143-21DA-46B7-B8A9-6ACA5C85D74C @default.
- Q104484307 P356 Q104484307-0DE2D453-53D5-46F2-97EC-0D3FBE2B002C @default.
- Q104484307 P478 Q104484307-B39C9DDF-CC2D-47C1-813B-DC0F55ED3C2E @default.
- Q104484307 P50 Q104484307-0D295EDA-E8EB-448C-8745-D96AACB075ED @default.
- Q104484307 P50 Q104484307-3B34A405-D58B-4A2B-B765-9944D1273DD4 @default.
- Q104484307 P50 Q104484307-6B01EFF9-0FD8-4CC0-8CBA-E61D0051CCE3 @default.
- Q104484307 P50 Q104484307-752C52FC-2699-4185-9777-3FBB3228D6F4 @default.
- Q104484307 P50 Q104484307-8826A87C-6384-4E0F-BCBD-744DD68962F6 @default.
- Q104484307 P50 Q104484307-ABF93652-FF16-4545-825D-9C56F39F6CAB @default.
- Q104484307 P577 Q104484307-78302EE4-91AD-41A0-909E-82EF8CF70B24 @default.
- Q104484307 P698 Q104484307-2B9E0242-6B52-43AB-A56C-5DD1546B2EDC @default.
- Q104484307 P932 Q104484307-FB11B8BF-5AA7-4AE3-81EC-E49A216C4172 @default.
- Q104484307 P356 J.BREAST.2020.12.004 @default.
- Q104484307 P698 33326894 @default.
- Q104484307 P1433 Q7719928 @default.
- Q104484307 P1476 "Impact of molecular subtype on 1325 early-stage breast cancer patients homogeneously treated with hypofractionated radiotherapy without boost: Should the indications for radiotherapy be more personalized?" @default.
- Q104484307 P2093 "Andrei Fodor" @default.
- Q104484307 P2093 "Aniko M Deli" @default.
- Q104484307 P2093 "Anna Chiara" @default.
- Q104484307 P2093 "Barbara Longobardi" @default.
- Q104484307 P2093 "Chiara Brombin" @default.
- Q104484307 P2093 "Chiara L Deantoni" @default.
- Q104484307 P2093 "Flavia Zerbetto" @default.
- Q104484307 P2093 "Fulvio Borroni" @default.
- Q104484307 P2093 "Giampaolo Bianchini" @default.
- Q104484307 P2093 "Italo Dell'Oca" @default.
- Q104484307 P2093 "Lucia Perna" @default.
- Q104484307 P2093 "Marcella Pasetti" @default.
- Q104484307 P2093 "Mariaclelia S Di Serio" @default.
- Q104484307 P2093 "N G Di Muzio" @default.
- Q104484307 P2093 "Najla Slim" @default.
- Q104484307 P2093 "Oreste D Gentilini" @default.
- Q104484307 P2093 "Paolo Passoni" @default.
- Q104484307 P2093 "Pier Giorgio Esposito" @default.
- Q104484307 P2093 "Roberta Tummineri" @default.
- Q104484307 P2093 "Simone Baroni" @default.
- Q104484307 P2093 "Stefano L Villa" @default.
- Q104484307 P2860 Q34054354 @default.
- Q104484307 P304 "45-54" @default.
- Q104484307 P31 Q13442814 @default.
- Q104484307 P356 "10.1016/J.BREAST.2020.12.004" @default.
- Q104484307 P478 "55" @default.
- Q104484307 P50 Q110644139 @default.
- Q104484307 P50 Q114417916 @default.
- Q104484307 P50 Q74817290 @default.
- Q104484307 P50 Q84411899 @default.
- Q104484307 P50 Q87650699 @default.
- Q104484307 P50 Q96189531 @default.
- Q104484307 P577 "2020-12-09T00:00:00Z" @default.
- Q104484307 P698 "33326894" @default.
- Q104484307 P932 "7736720" @default.